Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CytoMed Therapeutics (GDTC)

CytoMed Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GDTC
DateTimeSourceHeadlineSymbolCompany
24/05/202416:12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GDTCCytoMed Therapeutics Ltd
23/05/202411:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GDTCCytoMed Therapeutics Ltd
18/03/202410:00GlobeNewswire Inc.CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision TherapiesNASDAQ:GDTCCytoMed Therapeutics Ltd
04/03/202410:00GlobeNewswire Inc.CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and RepairNASDAQ:GDTCCytoMed Therapeutics Ltd
29/01/202412:00GlobeNewswire Inc.Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell TechnologyNASDAQ:GDTCCytoMed Therapeutics Ltd
05/12/202312:30PR Newswire (US)CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell TechnologyNASDAQ:GDTCCytoMed Therapeutics Ltd
17/11/202314:21PR Newswire (US)CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate UpdateNASDAQ:GDTCCytoMed Therapeutics Ltd
14/11/202312:47PR Newswire (US)CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor ConferenceNASDAQ:GDTCCytoMed Therapeutics Ltd
25/09/202312:00PR Newswire (US)Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based TechnologyNASDAQ:GDTCCytoMed Therapeutics Ltd
15/08/202318:00PR Newswire (US)CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo PersistencyNASDAQ:GDTCCytoMed Therapeutics Ltd
01/08/202312:00PR Newswire (US)Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell TechnologyNASDAQ:GDTCCytoMed Therapeutics Ltd
06/07/202312:00PR Newswire (US)A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the USNASDAQ:GDTCCytoMed Therapeutics Ltd
11/05/202314:00PR Newswire (US)CytoMed Therapeutics to Ring Nasdaq Closing BellNASDAQ:GDTCCytoMed Therapeutics Ltd
09/05/202315:07PR Newswire (US)CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in OncologyNASDAQ:GDTCCytoMed Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:GDTC